A Phase I, open-label, multicenter, study of WVT078 in subjects with relapsed and/or refractory multiple myeloma

  • Spencer, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date6/11/19 → 31/12/24

Keywords

  • Malignant Haematology
  • Multiple myeloma
  • Clinical trial